AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 146 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $1,112,000 | +43.7% | 85,625 | +53.1% | 0.22% | +45.9% |
Q4 2020 | $774,000 | +287.0% | 55,943 | +313.0% | 0.15% | +393.3% |
Q3 2020 | $200,000 | -50.7% | 13,544 | -45.8% | 0.03% | -63.0% |
Q2 2020 | $406,000 | -34.2% | 25,000 | -41.2% | 0.08% | -68.4% |
Q1 2020 | $617,000 | – | 42,500 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |